Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanjo Belz

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Urology|September 10, 2023
Metastatic Kidney Cancer?Michael Froehner, Hans-Egbert Schroeder, Hanjo Belz, et al.
Aktuelle Urologie|April 9, 2020
[Early- vs. late-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy]Axel S Merseburger, Christoph Rüssel, Hanjo Belz, et al.
European Urology Focus|December 26, 2021
Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma after Prior Therapy: Interim Results from the Noninterventional NORA StudyMarc-Oliver Grimm, Viktor Grünwald, Harald Müller-Huesmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2019
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric StudyKlaus-Peter Dieckmann, Arlo Radtke, Lajos Geczi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Urology|September 10, 2023
Metastatic Kidney Cancer?Michael Froehner, Hans-Egbert Schroeder, Hanjo Belz, et al.
Aktuelle Urologie|April 9, 2020
[Early- vs. late-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy]Axel S Merseburger, Christoph Rüssel, Hanjo Belz, et al.
European Urology Focus|December 26, 2021
Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma after Prior Therapy: Interim Results from the Noninterventional NORA StudyMarc-Oliver Grimm, Viktor Grünwald, Harald Müller-Huesmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2019
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric StudyKlaus-Peter Dieckmann, Arlo Radtke, Lajos Geczi, et al.
Pageof 1